GONADOTROPIN-RELEASING HORMONE ANALOGUES: COMPARING LONG AND SHORT PROTOCOL IN IVF OUTCOMES AT PRINCE RASHED MILITARY HOSPITAL
Keywords:
GnRH analogues, Pregnancy rateAbstract
Objective: To examine whether the outcomes of IVF cycles would vary according to the selected stimulation protocol. Method: The subjects of this retrospective descriptive inquiry are infertile patients who completed IVF treatment cycles at the Prince Rashed Military Hospital from May 2022 to February 2023. Comparisons were drawn between different stimulation protocols using GnRH analogues. The variables examined included the rate of pregnancy, rate of cancellation, total dosage of gonadotropin needed to affect stimulation, levels of serum estradiol on hCG administration day, total of follicles punctured, complexes that have been retrieved, total of oocytes that have matured, as well as attained embryos. Results: The cycle outcomes based on the stimulation protocol used for the studied variables showed no statistically significant differences. Conclusion: There are no differences in the IVF cycle outcomes with the use of GnRH analogues. Further research with larger sample sizes is necessary to identify the optimal treatment for each patient to achieve the best results.
References
1. H. M. Wu, H. M. Chang, and P. C. Leung, "Gonadotropin-releasing hormone analogs: Mechanisms of action and clinical applications in female reproduction," Frontiers in Neuroendocrinology, vol. 60, p. 100876, 2021.
2. G. Emons and C. Gründker, "The role of gonadotropin-releasing hormone (GnRH) in endometrial cancer," Cells, vol. 10, no. 2, p. 292, 2021.
3. F. L. Saleh and H. S. Taylor, "Clinical applications of gonadotropin-releasing hormone analogues: a broad impact on reproductive medicine," F&S Reports, vol. 4, no. 2, pp. 83-87, 2023.
4. M. Ali, M. Raslan, M. Ciebiera, K. Zaręba, and A. Al-Hendy, "Current approaches to overcome the side effects of GnRH analogs in the treatment of patients with uterine fibroids," Expert Opinion on Drug Safety, vol. 21, no. 4, pp. 477-486, 2022.
5. A. M. Kotlyar, L. Pal, and H. S. Taylor, "Eliminating hormones with orally active gonadotropin-releasing hormone antagonists," Clinical Obstetrics and Gynecology, vol. 64, no. 4, pp. 837-849, 2021.
6. Y. Mizrachi, E. Horowitz, J. Farhi, A. Raziel, and A. Weissman, "Ovarian stimulation for freeze-all IVF cycles: a systematic review," Human Reproduction Update, vol. 26, no. 1, pp. 119-136, 2020.
7. S. Kadoura, M. Alhalabi, and A. H. Nattouf, "Conventional GnRH antagonist protocols versus long GnRH agonist protocol in IVF/ICSI cycles of polycystic ovary syndrome women: a systematic review and meta-analysis," Scientific Reports, vol. 12, no. 1, p. 4456, 2022.
8. J. Zhu, W. Xing, T. Li, H. Lin, and J. Ou, "GnRH antagonist protocol versus GnRH agonist long protocol: a retrospective cohort study on clinical outcomes and maternal-neonatal safety," Frontiers in Endocrinology, vol. 13, p. 875779, 2022.
9. R. Yang, Y. Guan, V. Perrot, J. Ma, and R. Li, "Comparison of the long-acting GnRH agonist follicular protocol with the GnRH antagonist protocol in women undergoing in vitro fertilization: a systematic review and meta-analysis," Advances in Therapy, vol. 38, pp. 2027-2037, 2021.
10. J. Llácer et al., "Luteal phase stimulation versus follicular phase stimulation in poor ovarian responders: results of a randomized controlled trial," Reproductive Biology and Endocrinology, vol. 18, p. 1-8, 2020.
11. R. Yang, Y. Guan, V. Perrot, J. Ma, and R. Li, "Comparison of the long-acting GnRH agonist follicular protocol with the GnRH antagonist protocol in women undergoing in vitro fertilization: a systematic review and meta-analysis," Advances in Therapy, vol. 38, pp. 2027-2037, 2021.
12. R. Kabodmehri et al., "Pregnancy outcome in long-versus short-acting gonadotropin-releasing hormone agonist cycles in participants with normal ovarian reserve: An RCT," International Journal of Reproductive BioMedicine, vol. 21, no. 9, p. 759, 2023.
13. C. Liu et al., "Live birth rate of gonadotropin-releasing hormone antagonist versus luteal phase gonadotropin-releasing hormone agonist protocol in IVF/ICSI: a systematic review and meta-analysis," Expert Reviews in Molecular Medicine, pp. 1-30, 2023.
14. C. A. Venetis et al., "What is the optimal GnRH antagonist protocol for ovarian stimulation during ART treatment? A systematic review and network meta-analysis," Human Reproduction Update, vol. 29, no. 3, pp. 307-326, 2023.
15. N. Wang et al., "Comparison of a progestin-primed ovarian stimulation protocol with a flexible GnRH antagonist protocol in patients with polycystic ovary syndrome who are participating in an IVF programme: study protocol for a randomised controlled trial," BMJ Open, vol. 10, no. 12, p. e038153, 2020.
16. C. Siristatidis et al., "A randomized controlled trial on the efficacy and safety of low-dose hCG in a short protocol with GnRH agonist and ovarian stimulation with recombinant FSH (rFSH) during the follicular phase in infertile women undergoing ART," Reproductive Sciences, vol. 29, no. 2, pp. 497-505, 2022.
17. W. Zhang, Z. Liu, M. Liu, J. Li, and Y. Guan, "Is it necessary to monitor the serum luteinizing hormone (LH) concentration on the human chorionic gonadotropin (HCG) day among young women during the follicular-phase long protocol? A retrospective cohort study," Reproductive Biology and Endocrinology, vol. 20, no. 1, p. 24, 2022.
18. A. Salameh, S. Faour, and J. Awwad, "The Use of GnRH Agonists to Trigger Final Oocyte Maturation during Controlled Ovarian Stimulation," Ovarian Stimulation, p. 282, 2022.
19. S. Palomba et al., "Interventions to prevent or reduce the incidence and severity of ovarian hyperstimulation syndrome: a systematic umbrella review of the best clinical evidence," Reproductive Biology and Endocrinology, vol. 21, no. 1, p. 67, 2023.
20. D. F. Du, M. F. Li, and X. L. Li, "Ovarian hyperstimulation syndrome: a clinical retrospective study on 565 inpatients," Gynecological Endocrinology, vol. 36, no. 4, pp. 313-317, 2020.
